08Jul/13

Cell Therapeutics' Pixuvri receives marketing approval from Italian Medicines … – pharmabiz.com

Cell Therapeutics’ Pixuvri receives marketing approval from Italian Medicines
pharmabiz.com
The European Medicines Agency’s (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled phase III clinical trial, which compares Pixuvri-rituximab to gemcitabine-rituximab in patients who have 

and more »

08Jul/13

WellPoint, Aetna, Humana test wireless monitoring for congestive heart failure – FierceMobileHealthcare (press release)

WellPoint, Aetna, Humana test wireless monitoring for congestive heart failure
FierceMobileHealthcare (press release)
One of the main barriers to widespread adoption of wireless home patient monitors is that insurers have been reluctant to pay for the technology. Granted, there isn’t much scientific literature yet to support reimbursement for such devices, but several